Heterogeneity of HSCs in a Mouse Model of NASH.

Sara Brin Rosenthal, Xiao Liu, Souradipta Ganguly, Debanjan Dhar, Martina P Pasillas, Eugenia Ricciardelli, Rick Z Li, Ty D Troutman, Tatiana Kisseleva, Christopher K Glass, David A Brenner

Hepatology (Baltimore, Md.) 2021 Aug

filter terms:

In clinical and experimental NASH, the origin of the scar-forming myofibroblast is the HSC. We used foz/foz mice on a Western diet to characterize in detail the phenotypic changes of HSCs in a NASH model. We examined the single-cell expression profiles (scRNA sequencing) of HSCs purified from the normal livers of foz/foz mice on a chow diet, in NASH with fibrosis of foz/foz mice on a Western diet, and in livers during regression of NASH after switching back to a chow diet. Selected genes were analyzed using immunohistochemistry, quantitative real-time PCR, and short hairpin RNA knockdown in primary mouse HSCs. Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either pericentral vein or periportal vein. The NASH livers had four distinct HSC clusters, including one representing the classic fibrogenic myofibroblast. The three other HSC clusters consisted of a proliferating cluster, an intermediate activated cluster, and an immune and inflammatory cluster. The livers with NASH regression had one cluster of inactivated HSCs, which was similar to, but distinct from, the quiescent HSCs. Analysis of single-cell RNA sequencing in combination with an interrogation of previous studies revealed an unanticipated heterogeneity of HSC phenotypes under normal and injured states. © 2021 by the American Association for the Study of Liver Diseases.

Citation

Sara Brin Rosenthal, Xiao Liu, Souradipta Ganguly, Debanjan Dhar, Martina P Pasillas, Eugenia Ricciardelli, Rick Z Li, Ty D Troutman, Tatiana Kisseleva, Christopher K Glass, David A Brenner. Heterogeneity of HSCs in a Mouse Model of NASH. Hepatology (Baltimore, Md.). 2021 Aug;74(2):667-685